"Graft Rejection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
| Descriptor ID |
D006084
|
| MeSH Number(s) |
G12.875.545.328
|
| Concept/Terms |
Graft Rejection- Graft Rejection
- Graft Rejections
- Rejection, Graft
- Rejections, Graft
- Transplant Rejection
- Transplantation Rejection
- Rejection, Transplantation
- Rejections, Transplantation
- Transplantation Rejections
- Rejection, Transplant
- Rejections, Transplant
- Transplant Rejections
|
Below are MeSH descriptors whose meaning is more general than "Graft Rejection".
Below are MeSH descriptors whose meaning is more specific than "Graft Rejection".
This graph shows the total number of publications written about "Graft Rejection" by people in this website by year, and whether "Graft Rejection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 6 | 1 | 7 |
| 2013 | 0 | 2 | 2 |
| 2014 | 2 | 3 | 5 |
| 2015 | 2 | 0 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 81 | 48 | 129 |
| 2018 | 90 | 39 | 129 |
| 2019 | 37 | 20 | 57 |
| 2020 | 23 | 15 | 38 |
| 2021 | 9 | 14 | 23 |
To return to the timeline, click here.
Below are the most recent publications written about "Graft Rejection" by people in Profiles.
-
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies. Transplantation. 2021 11 01; 105(11):e234-e243.
-
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. Transplantation. 2021 11 01; 105(11):e265-e266.
-
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant. Transplantation. 2021 11 01; 105(11):e267-e269.
-
Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium. Transplantation. 2021 11 01; 105(11):e257-e258.
-
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients. Transplantation. 2021 11 01; 105(11):e226-e233.
-
Kidney allograft biopsy findings after COVID-19. Am J Transplant. 2021 12; 21(12):4032-4042.
-
Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study. Transplantation. 2021 09 01; 105(9):2072-2079.
-
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123.
-
Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy. Am J Transplant. 2022 01; 22(1):289-293.
-
Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine. Cornea. 2021 08 01; 40(8):1070-1072.